Evidence map›Paper›PMID 35676548›Full record

ArticleBiochemical genetics2022

CircCERS6 Suppresses the Development of Epithelial Ovarian Cancer Through Mediating miR-630/RASSF8.

Xiaoqin Li, Xuemei Jiang, Jing Lu, Yuting Lin, Lan Jiang, Yan Li, Feng Wan, Changmin Wang

Abstract read
PubMed Publisher
In one paragraph

Article in Biochemical genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Xiaoqin Li *Clinical Laboratory, Urumqi Maternal and Child Health Care Hospital, Urumqi, Xinjiang, China.
Xuemei Jiang *Clinical Laboratory, Urumqi Maternal and Child Health Care Hospital, Urumqi, Xinjiang, China.
Jing LuDepartment of Gynecology, Urumqi Maternal and Child Health Care Hospital, Urumqi, Xinjiang, China.
Yuting LinClinical Laboratory, Urumqi Maternal and Child Health Care Hospital, Urumqi, Xinjiang, China.
Lan JiangClinical Laboratory, Urumqi Maternal and Child Health Care Hospital, Urumqi, Xinjiang, China.
Yan LiClinical Laboratory, Urumqi Maternal and Child Health Care Hospital, Urumqi, Xinjiang, China.
Feng WanClinical Laboratory, Urumqi Maternal and Child Health Care Hospital, Urumqi, Xinjiang, China.
Changmin WangClinical Laboratory Center, People's Hospital of Xinjiang Uygur Autonomous Region, Tianshan District, No. 91 Tianchi Road, Urumqi, 830001, Xinjiang, China. wcm224@126.com.
Maternal and Child Health Hospital of Xinjiang Uygur Autonomous Region · CNPeople's Hospital of Xinjiang Uygur Autonomous Region · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accumulating evidence have demonstrated that circular RNAs (circRNAs) exert important roles in tumor initiation and progression. Nevertheless, the role and mechanism of circRNA ceramide synthase 6 (circCERS6) in epithelial ovarian cancer (EOC) remain to be clarified. Using reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and Western blot assay, we measured RNA and protein expression. We analyzed the effects of circCERS6/microRNA-630 (miR-630)/Ras-association domain family member 8 (RASSF8) axis in cell proliferation, migration, and invasion by 5-Ethynyl-2'-deoxyuridine (EdU) assay, colony formation assay, scratch test, and transwell assay. Using RNA-pull down assay and dual-luciferase reporter assay, the interaction between miR-630 and circCERS6 or RASSF8 was verified. The in vivo role of circCERS6 in tumor growth was analyzed using xenograft mice model. CircCERS6 expression was markedly reduced in EOC tissues and cell lines. CircCERS6 overexpression hampered the proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT) of EOC cells. CircCERS6 directly interacted with miR-630. miR-630 expression was up-regulated in EOC tissues and cell lines. CircCERS6 overexpression-induced anti-tumor effects in EOC were largely reversed by the overexpression of miR-630. RASSF8 was a direct target of miR-630. RASSF8 level was decreased in EOC tissues and cell lines. CircCERS6 up-regulated RASSF8 expression by acting as a molecular sponge for miR-630 in EOC cells. CircCERS6 overexpression-mediated suppressive effects in EOC cells were largely overturned by the silence of RASSF8. CircCERS6 overexpression blocked tumor growth in vivo. CircCERS6 overexpression hampered the proliferation, migration, invasion, and EMT of EOC cells by up-regulating RASSF8 via sponging miR-630.

Indexed as

Carcinoma, Ovarian EpithelialMicroRNAsOvarian NeoplasmsRNA, CircularTumor Suppressor ProteinsAnimalsCell Line, TumorCell MovementCell ProliferationFemaleGene Expression Regulation, NeoplasticHumansMiceMicroRNAsMIRN630 microRNA, humanRASSF8 protein, humanRNA, CircularTumor Suppressor ProteinscircCERS6Epithelial ovarian cancermiR-630RASSF8

Identifiers

PMID35676548
OpenAlexW4282939908

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.